Summary
Areas of interest at LeirasOrganization name
Leiras Finland business developmentProfile
Leiras is an expert on Finnish health care - a pharmaceutical company with a unique operating concept that allows it to introduce new, innovative products to the Finnish market quickly.
Leiras' parent company Nycomed identifies top products in the biotechnology and pharmaceuticals sectors throughout the world and then invests in R&D in these products. Leiras selects the best products for Finnish customers from among the innovations produced at dozens of research units.
The core areas for Leiras are
- cardiovascular diseases
- arthrosis and osteoporosis
- and hospital and self-care products
In-licensing is a top strategic priority for Leiras Finland since they do not conduct basic research for the discovery of new products. Partnerships with numerous pharmaceutical companies are at the heart of their approach to healthcare. They cooperate with other pharmaceutical companies by commercialising their findings. This is how we expand our product portfolio, and thus, support our growth in Finland.
They are looking for new products in:
GP area
- to complement current GP portfolio
- to broaden their existing portfolio in a wide range of indications handled by GP's
Hospital area
- to complement current hospital portfolio
- i.v. antibiotics
- semi modern cancer drugs and adjunctive products for cancer treatment
OTC area
- topical creams containing active pharmaceutical ingredient
- smoking cessation products
- laxatives and other products for GI problems
Additional information and contact data are provided online.
print this page
